Grade

Name: 2º PÓS WCLC CÂNCER DE PULMÃO ONCOCLÍNICAS
Start: 2022-03-31
End: 2022-03-31
Location: Evento Online

23/09/2021 (Quinta-feira)

	Auditório
19:00	19:00 - 19:05 Dia 23 de setembro ABERTURA CLARISSA MATHIAS Chair ANA GELATTI Chair CARLOS GIL Chair BRUNO FERRARI Chair
19:05	19:05 - 19:45 Pulmão BLOCO 1 - HIGHLIGHTS: SCREENING / TABAGISMO / EPIDEMIOLOGIA / PESQUISA MARIANA LALONI Chair CLARISSA MATHIAS Debatedora 19:05 - 19:10 PL02.07 - Global Variability in Lung Cancer Deaths Attributable to Air Pollution ELEAN GIUSTI Palestrante 19:10 - 19:15 PL02.09 - International Association for the Study of Lung Cancer (IASLC) Study of the Impacts of COVID-19 on International Lung Cancer Clinical Trials PEDRO NAZARETH AGUIAR JUNIOR SAO PAULO / SP Palestrante 19:15 - 19:20 PL03.02 - Lung Cancer Screening in Latin America: Current Status and Challenges BRUNO HOCHHEGGER PORTO ALEGRE / RS Palestrante 19:20 - 19:45 Discussão
19:45	19:45 - 20:15 Pulmão BLOCO 2 - HIGHLIGHTS: ESTADIO I-II TATIANE MONTELLA Chair RICARDO OLIVEIRA - Debatedor MARIA TERESA TSUKAZAN Debatedora FLÁVIA AMARAL Debatedora 19:45 - 19:50 PL02.05 - IMpower010: Characterization of Stage IB-IIIA NSCLC Patients by Tye and Extend of Therapy Prior to Adjuvant Atezolizumab MARINA KELNER RECIFE / PE Palestrante 19:50 - 19:55 OA11.01 - Neoadjuvant Pembrolizumab for Early Stage Non-Small Cell Lung Cancer 19:55 - 20:00 OA11.03 - Survival and Prognostic Factors of Resected T3N0M0 NSCLC DANIEL BONOMI Palestrante 20:00 - 20:15 Discussão
20:15	20:15 - 20:35 Pulmão Aula Magna MARIANO ZALIS Chair 20:15 - 20:30 Atualizações sobre biópsia líquida em câncer de pulmão RODRIGO DIENSTMANN SAO PAULO / SP Palestrante 20:30 - 20:35 Encerramento CLARISSA MATHIAS Chair ANA GELATTI Chair
20:35

Legenda

Dia 23 de setembro
Pulmão

24/09/2021 (Sexta-feira)

	Auditório
18:55	18:55 - 19:00 Dia 24 de setembro ABERTURA CLARISSA MATHIAS Chair ANA GELATTI Chair
19:00	19:00 - 19:30 Pulmão BLOCO 3 - HIGHLIGHTS ESTADIO III e IV (imunoterapia) ANA GELATTI Chair RAFAEL LESSA Debatedor VINICIUS LORANDI PORTO ALEGRE / RS Debatedor 19:00 - 19:05 OA11.04 - Impact of Local Control on Cause-Specific Survival After SBRT for Early-Stage NSCLC: Dynamic Prediction With Landmarking THARCISIO COELHO Palestrante 19:05 - 19:10 PL02.01 - Durvalumab ± Tremelimumab + Chemotherapy as First-line Treatment for mNSCLC: Results from the Phase 3 POSEIDON Study FLÁVIA AMARAL Palestrante 19:10 - 19:15 OA09.01 - First-line Nivolumab + Ipilimumab + Chemo in Patients With Advanced NSCLC and Brain Metastases: Results From CheckMate 9LA JULIANO CE Palestrante 19:15 - 19:20 OA09.03 - Pembrolizumab in Combination With Platinum-Based Chemotherapy in Recurrent EGFR/ALK-Positive Non-Small Cell Lung Cancer (NSCLC) TERCIA REIS Palestrante 19:20 - 19:30 Discussão
19:30	19:30 - 20:00 Pulmão BLOCO 4 - HIGHLIGHTS: ESTADIO IV (terapia alvo) e DOENÇA OLIGOMETASTÁTICA JACQUES TABACOF SAO PAULO / SP Chair JEAN PEREIRA JOAO PESSOA / PB Debatedor ELGE WERNECK Debatedor 19:30 - 19:35 OA15.03 - Amivantamab in Non-small Cell Lung Cancer (NSCLC) with MET Exon 14 Skipping (METex14) Mutation: Initial Results from CHRYSALIS VINICIUS LORANDI PORTO ALEGRE / RS Palestrante 19:35 - 19:40 OA15.04 - Telisotuzumab Vedotin (teliso-v) Monotherapy in Patients With Previously Treated c-Met+ Advanced Non-Small Cell Lung Cancer DENISE LEITE SAO PAULO / SP Palestrante 19:40 - 19:45 § MA01.01 - The Role of Surgery for M1a Non-Small-Cell Lung Cancer with Contralateral Lung Involvement JOÃO DUTRA Palestrante 19:45 - 19:50 MA01.02 - Surgical Complexity of Pulmonary Resections Performed for Oligometastatic Non-Small Cell Lung Cancer MARIA TERESA TSUKAZAN Palestrante 19:50 - 20:00 Discussão
20:00	20:00 - 20:35 Pulmão Aulas Magnas CARLOS GIL Chair 20:00 - 20:15 O que o WCLC 2021 muda na Cirurgia? PAULA UGALDE BOSTON / MA Palestrante 20:15 - 20:30 O que o WCLC 2021 muda na Oncologia Clínica? TATIANE MONTELLA Palestrante 20:30 - 20:35 Encerramento CLARISSA MATHIAS Chair ANA GELATTI Chair
20:35